Effects of IL-1 Beta on the HPA-axis in Obese Persons

NCT02227420 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome
Hypersecretion; Cortisol

Interventions

DRUG: Anakinra

Sponsor

University Hospital, Basel, Switzerland